CA9 and neoplasm: Several carbonic anhydrase (CA) isoforms, specifically hCA (human carbonic anhydrase) IX and XII exhibit active participation in these hypoxic tumours related metabolic processes and have been validated as antimetastatic or anti-tumour drug targets.4